BofA/Merrill Lynch downgraded Aetna (NYSE: AET) from Buy to Neutral and maintained their $94 price target, citing more upside elswhere.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE